USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis
USA - NYSE:USNA - US90328M1071 - Common Stock
19.13 USD
-0.03 (-0.16%)
19.13 USD
0 (0%)
Taking everything into account, USNA scores 5 out of 10 in our fundamental rating. USNA was compared to 34 industry peers in the Personal Care Products industry. While USNA has a great health rating, its profitability is only average at the moment. USNA has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
USNA had positive earnings in the past year.
USNA had a positive operating cash flow in the past year.
Each year in the past 5 years USNA has been profitable.
Each year in the past 5 years USNA had a positive operating cash flow.
1.2 Ratios
USNA has a better Return On Assets (4.64%) than 61.76% of its industry peers.
USNA's Return On Equity of 6.42% is fine compared to the rest of the industry. USNA outperforms 67.65% of its industry peers.
With a Return On Invested Capital value of 5.38%, USNA perfoms like the industry average, outperforming 55.88% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for USNA is below the industry average of 12.43%.
The 3 year average ROIC (10.32%) for USNA is well above the current ROIC(5.38%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.64% | ||
| ROE | 6.42% | ||
| ROIC | 5.38% |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
1.3 Margins
The Profit Margin of USNA (3.79%) is better than 61.76% of its industry peers.
USNA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 6.25%, USNA is in line with its industry, outperforming 58.82% of the companies in the same industry.
In the last couple of years the Operating Margin of USNA has declined.
With an excellent Gross Margin value of 79.93%, USNA belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
USNA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.25% | ||
| PM (TTM) | 3.79% | ||
| GM | 79.93% |
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), USNA is creating some value.
Compared to 1 year ago, USNA has less shares outstanding
The number of shares outstanding for USNA has been reduced compared to 5 years ago.
The debt/assets ratio for USNA is higher compared to a year ago.
2.2 Solvency
USNA has an Altman-Z score of 3.64. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.64, USNA is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
USNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.64 |
ROIC/WACC0.64
WACC8.47%
2.3 Liquidity
USNA has a Current Ratio of 2.15. This indicates that USNA is financially healthy and has no problem in meeting its short term obligations.
USNA has a Current ratio (2.15) which is in line with its industry peers.
A Quick Ratio of 1.47 indicates that USNA should not have too much problems paying its short term obligations.
USNA has a Quick ratio (1.47) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.47 |
3. Growth
3.1 Past
USNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.74%.
The earnings per share for USNA have been decreasing by -10.07% on average. This is quite bad
USNA shows a small growth in Revenue. In the last year, the Revenue has grown by 5.88%.
USNA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.23% yearly.
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%
3.2 Future
USNA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.69% yearly.
Based on estimates for the next years, USNA will show a small growth in Revenue. The Revenue will grow by 2.77% on average per year.
EPS Next Y-32.13%
EPS Next 2Y-9.23%
EPS Next 3Y2.69%
EPS Next 5YN/A
Revenue Next Year8.32%
Revenue Next 2Y3.08%
Revenue Next 3Y2.77%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
USNA is valuated reasonably with a Price/Earnings ratio of 9.76.
Based on the Price/Earnings ratio, USNA is valued cheaply inside the industry as 85.29% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of USNA to the average of the S&P500 Index (26.06), we can say USNA is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.93, the valuation of USNA can be described as very reasonable.
USNA's Price/Forward Earnings ratio is rather cheap when compared to the industry. USNA is cheaper than 82.35% of the companies in the same industry.
USNA is valuated cheaply when we compare the Price/Forward Earnings ratio to 32.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.76 | ||
| Fwd PE | 8.93 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 97.06% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.48 |
4.3 Compensation for Growth
The decent profitability rating of USNA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.23%
EPS Next 3Y2.69%
5. Dividend
5.1 Amount
No dividends for USNA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
19.13
-0.03 (-0.16%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners61.34%
Inst Owner Change0.41%
Ins Owners0.61%
Ins Owner Change-0.01%
Market Cap349.51M
Revenue(TTM)912.67M
Net Income(TTM)34.12M
Analysts43.33
Price Target39.78 (107.95%)
Short Float %7.2%
Short Ratio4.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.3%
Min EPS beat(2)2.24%
Max EPS beat(2)34.35%
EPS beat(4)4
Avg EPS beat(4)19.49%
Min EPS beat(4)2.24%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)17.25%
EPS beat(12)9
Avg EPS beat(12)21.2%
EPS beat(16)10
Avg EPS beat(16)13.82%
Revenue beat(2)2
Avg Revenue beat(2)1.7%
Min Revenue beat(2)0.66%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.23%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.39%
Revenue beat(12)7
Avg Revenue beat(12)-0.44%
Revenue beat(16)9
Avg Revenue beat(16)-0.74%
PT rev (1m)-36.07%
PT rev (3m)-36.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-33.97%
EPS NY rev (3m)-33.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-3.57%
Revenue NY rev (3m)-3.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.76 | ||
| Fwd PE | 8.93 | ||
| P/S | 0.39 | ||
| P/FCF | N/A | ||
| P/OCF | 5.55 | ||
| P/B | 0.66 | ||
| P/tB | 1.43 | ||
| EV/EBITDA | 2.48 |
EPS(TTM)1.96
EY10.25%
EPS(NY)2.14
Fwd EY11.2%
FCF(TTM)-8.34
FCFYN/A
OCF(TTM)3.45
OCFY18.03%
SpS49.22
BVpS29.07
TBVpS13.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.64% | ||
| ROE | 6.42% | ||
| ROCE | 9.17% | ||
| ROIC | 5.38% | ||
| ROICexc | 7.14% | ||
| ROICexgc | 18.89% | ||
| OM | 6.25% | ||
| PM (TTM) | 3.79% | ||
| GM | 79.93% | ||
| FCFM | N/A |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
ROICexc(3y)25.77%
ROICexc(5y)39.61%
ROICexgc(3y)41.63%
ROICexgc(5y)58.84%
ROCE(3y)17.59%
ROCE(5y)26.19%
ROICexgc growth 3Y-27.3%
ROICexgc growth 5Y-19.15%
ROICexc growth 3Y-45.52%
ROICexc growth 5Y-31.11%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
F-Score5
Asset Turnover1.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 910.64% | ||
| Cap/Sales | 23.95% | ||
| Interest Coverage | 84.38 | ||
| Cash Conversion | 78.92% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.47 | ||
| Altman-Z | 3.64 |
F-Score5
WACC8.47%
ROIC/WACC0.64
Cap/Depr(3y)569.36%
Cap/Depr(5y)383.35%
Cap/Sales(3y)9.41%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
EPS Next Y-32.13%
EPS Next 2Y-9.23%
EPS Next 3Y2.69%
EPS Next 5YN/A
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%
Revenue Next Year8.32%
Revenue Next 2Y3.08%
Revenue Next 3Y2.77%
Revenue Next 5YN/A
EBIT growth 1Y-33.36%
EBIT growth 3Y-26.96%
EBIT growth 5Y-14.62%
EBIT Next Year56.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-291.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.5%
OCF growth 3Y-20.46%
OCF growth 5Y-13.6%
USANA HEALTH SCIENCES INC / USNA FAQ
What is the fundamental rating for USNA stock?
ChartMill assigns a fundamental rating of 5 / 10 to USNA.
What is the valuation status for USNA stock?
ChartMill assigns a valuation rating of 6 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Fairly Valued.
Can you provide the profitability details for USANA HEALTH SCIENCES INC?
USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 6 / 10.
How financially healthy is USANA HEALTH SCIENCES INC?
The financial health rating of USANA HEALTH SCIENCES INC (USNA) is 7 / 10.
What is the earnings growth outlook for USANA HEALTH SCIENCES INC?
The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to decline by -32.13% in the next year.